Harris, D.D.; Broadwin, M.; Stone, C.; Sabe, S.A.; Kanuparthy, M.; Nho, J.-W.; Muir, K.C.; Abid, M.R.; Sellke, F.W.
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome. Int. J. Mol. Sci. 2025, 26, 1887.
https://doi.org/10.3390/ijms26051887
AMA Style
Harris DD, Broadwin M, Stone C, Sabe SA, Kanuparthy M, Nho J-W, Muir KC, Abid MR, Sellke FW.
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome. International Journal of Molecular Sciences. 2025; 26(5):1887.
https://doi.org/10.3390/ijms26051887
Chicago/Turabian Style
Harris, Dwight D., Mark Broadwin, Christopher Stone, Sharif A. Sabe, Meghamsh Kanuparthy, Ju-Woo Nho, Kelsey C. Muir, M. Ruhul Abid, and Frank W. Sellke.
2025. "Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome" International Journal of Molecular Sciences 26, no. 5: 1887.
https://doi.org/10.3390/ijms26051887
APA Style
Harris, D. D., Broadwin, M., Stone, C., Sabe, S. A., Kanuparthy, M., Nho, J.-W., Muir, K. C., Abid, M. R., & Sellke, F. W.
(2025). Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome. International Journal of Molecular Sciences, 26(5), 1887.
https://doi.org/10.3390/ijms26051887
